Skip to main content
ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · IEX Real-Time Price · USD
122.30
-0.89 (-0.72%)
At close: Jul 19, 2024, 4:00 PM
122.37
+0.07 (0.06%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

ICU Medical Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ICU Medical stock have an average target of 127, with a low estimate of 110 and a high estimate of 136. The average target predicts an increase of 3.84% from the current stock price of 122.30.

Analyst Consensus: Buy
Target Low Average Median High
Price $110 $127 $135 $136
Change -10.06% +3.84% +10.38% +11.20%
* Price targets were last updated on Jun 17, 2024.

Analyst Ratings

The average analyst rating for ICU Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy 111111
Buy 222222
Hold 000011
Sell 000000
Strong Sell 000000
Total 333344

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Mike Matson
Needham
 Needham
Hold
Initiates
n/a
 Hold Initiates n/a n/a Jun 21, 2024
Jayson Bedford
Raymond James
 Raymond James
Buy
Upgrades
$135
 Buy Upgrades $135 +10.38% Jun 17, 2024
Brett Fishbin
Keybanc
 Keybanc
Buy
Maintains
$134 → $136
 Buy Maintains $134 → $136 +11.20% Feb 28, 2024
Brett Fishbin
Keybanc
 Keybanc
Buy
Initiates
$134
 Buy Initiates $134 +9.57% Feb 6, 2024
Kristen Stewart
CL King
 CL King
Strong Buy
Initiates
$110
 Strong Buy Initiates $110 -10.06% Dec 14, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
2.32B
from 2.26B
Increased by 2.78%
Revenue Next Year
2.41B
from 2.32B
Increased by 3.88%
EPS This Year
4.93
from -1.23
EPS Next Year
6.69
from 4.93
Increased by 35.80%
Year 2019202020212022202320242025202620272028
Revenue
1.27B1.27B1.32B2.28B2.26B2.32B2.41B2.44B2.52B2.60B
Revenue Growth
-9.56%0.38%3.56%73.21%-0.92%2.78%3.88%1.04%3.28%3.30%
EPS
4.694.024.74-3.11-1.234.936.698.6912.3714.12
EPS Growth
252.63%-14.29%17.91%---35.80%29.84%42.37%14.10%
Forward PE
-----24.8118.2714.079.888.66
No. Analysts -----77433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 2.4B 2.5B 2.5B 2.6B 2.7B
Avg 2.3B 2.4B 2.4B 2.5B 2.6B
Low 2.2B 2.3B 2.3B 2.4B 2.5B

Revenue Growth

Revenue Growth 20242025202620272028
High
6.1%
8.0%
4.0%
6.3%
6.3%
Avg
2.8%
3.9%
1.0%
3.3%
3.3%
Low
-1.7%
-2.1%
-2.9%
-0.8%
-0.8%

EPS Forecast

EPS 20242025202620272028
High 5.21 7.48 8.95 12.74 14.53
Avg 4.93 6.69 8.69 12.37 14.12
Low 4.55 6.08 8.35 11.89 13.56

EPS Growth

EPS Growth 20242025202620272028
High -
51.7%
33.7%
46.6%
17.5%
Avg -
35.8%
29.8%
42.4%
14.1%
Low -
23.3%
24.7%
36.8%
9.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.